The following PhD Students sucessfully completed their thesis within the EUTox Work group:
B. Näsström: Lipoprotein lipase in hemodialysis patients and healthy controls: effects of heparin.
V. Jankowski: Isolation, identification and characterization of vasoactive substances from endothelial cells, platelets and mononuclear cells.
P. Jonsson: Safety and biological aspects of present techniques of haemodialysis.
E. Schepers: In vitro research for the pathophysiological mechanisms of uremic retention solutes on leukocytes in relation to chronic inflammation and accelerated atheromatosis in chronic kidney diseases.
T. Guenthner:"Angioprotectin": a vasoprotective angiotensin peptide".
M. Koehler: Contribution of known uremic retention solutes to the development of cardiovascular diseases in patients with chronic kidney disease.
E. Houthuys: Transcriptome analysis of monocytes and macrophages in mycobactrial infection and chronic kidney disease.
M. Luman: Dialysis Dose and Nutrition Assessment by an Optical Method.
N. Meert: Optimisation of removal of uremic retention solutes by haemodialysis strategies.
S. Salem: Isolation and identification of vasomodulating biomolecules
A. Pletinck: The peritoneal membrane as a window for microvascular pathophysiology in chronic kidney disease.
F. Duranton: Natural history of chronic kidney disease. Analysis of pathophysiological and prognostic factors of renal failure and its complications.
J. Holmar: Optical Method for Uric Acid Removal Assessment During Dialysis.
B. Holmberg: Analysis of risk factors in patients with severe chronic kidney disease. The role of atovastatin.
D. Mahmood: Lipoprotein lipase activity is reduced in dialysis patients. Studies on possible causal factors.
U. Forsberg: Presence of microemboli during haemodialysis and methods to reduce the exposure to microbubbles.
F. Böhringer: Development of clinical methods for increased removal of protein-bound uremic toxins in the context of an extracorporeal therapy.
J. Boelaert: Development of metabolic analytical platforms for the characterization of uremic retention compounds.
N. Neirynck: Micro-inflammation and cardiovascular disease in chronic kidney disease: role of uremic peptides,
J. Siwy: Validation of an urinary classifier for diagnosis of diabetic nephropathy.
M. Rueth: Hydrophobe Metabolite: Proteinaffinität, Quantifizierung und Methodische Ansätze zur Untersuchung vaskulärer Effekte. Major Chromophores and Fluorophores in the Spent Dialysate as Cornerstones for Optical Monitoring of Kidney Replacement Therapy.
J. Arund: Major Chromophores and Fluorophores in the Spent Dialysate as Cornerstones for Optical Monitoring of Kidney Replacement Therapy.
A. Bhat: Bioinformatics Modeling of Proteomics changes in Muscle Invasive Bladder Cancer.
A. Latosinska: Optimizing methodologies for clinical proteomics.
M. Pejchinovski: The role of urinary peptide markers in diagnosis and prognosis of servere renal diseases.
S. Filip: Identification of protein biomarkers for chronic kidney disease progression using state-of-the-art proteomics approaches.
O. A. Deif: Documentation and evaluation of uremic retention solutes through an interactive database
C. Pontillo: Clinical peptidomics of non-invasive diagnosis and prognosis of renal diseases.